Trending Now
Subscribe to the Drug Discovery & Development (DDD) Newsletter
Drug Discovery and Development
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other...
$149 a month new oral GLP-1 pill for weight loss (Foundayo (orforglipron)) now available in the US
Eli Lilly and Company has announced that Foundayo™ (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the US Food...
European Commission approves Kygevvi (doxecitine and doxribtimine) as first and only treatment for thymidine kinase 2 deficiency
UCB, a global biopharmaceutical company, has announced that the European Commission (EC) has granted marketing authorisation under exceptional circumstances for Kygevvi (doxecitine and doxribtimine)...
Eisai and Nuvation Bio announce marketing authorisation application for taletrectinib for the treatment of advanced ROS1-positive non-small cell lung cancer validated by the European...
Eisai Co, a human-centred global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas, and Nuvation Bio, a global oncology company...
Zegfrovy (Sunvozertinib) shows profound antitumor activity as first-line treatment in advanced NSCLC patients with PACC or other uncommon mutations
Dizal, a biopharmaceutical company committed to developing novel medicines for cancer and immunological diseases, has announced the presentation of new clinical data for Zegfrovy® (sunvozertinib)...
India’s first DCGI-approved Semaglutide injection Obeda for type 2 diabetes launched
Dr. Reddy’s Laboratories Ltd has launched injectable semaglutide under the brand name Obeda®, marking an important step in expanding access to advanced GLP‑1 receptor...
FDA approval of Kresladi for paediatric patients with severe leukocyte adhesion deficiency-I (LAD-I)
The US Food and Drug Administration (FDA) has granted accelerated approval for Kresladi™ (marnetegragene autotemcel), an autologous haematopoietic stem cell-based gene therapy indicated for...
a-Klotho cell and gene therapy potential
Avaí Bio recently announced that it has initiated manufacturing of a master cell bank of genetically modified cells that overexpress the α-Klotho protein, working...
Clinical Trials Insight
Ebglyss (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
New long-term data shows Eli Lilly and Company's Ebglyss (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for patients with...
Bimzelx (bimekizumab-bkzx) data shows durable symptom control throughout three years in hidradenitis suppurativa
UCB, a global biopharmaceutical company, announced data for Bimzelx in active moderate-to-severe hidradenitis suppurativa (HS) at the 2026 American Academy of Dermatology (AAD) Annual...
Icotyde one-year results confirm lasting skin clearance and favourable safety profile in once-daily pill for plaque psoriasis
Johnson & Johnson has announced new long-term 52-week data from the phase 3 Iconic-advance 1 and 2 and Iconic-lead studies, which assessed the efficacy...
Adcytherix doses first patient in phase 1 trial of ADCX-020
Adcytherix, a biopharmaceutical company pioneering next-generation antibody-drug conjugates (ADCs), has announced the dosing of the first patient in the phase 1 clinical trial of...
CancerVax reports successful initial mouse study with breakthrough results
CancerVax, the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution...
VIDEOS
Pharma in Healthcare
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
The advisory board of Romaco Holding GmbH has appointed Nicola Magriotis as Chief Sales Officer (CSO) of the Romaco Group. By creating this new managerial...
New report finds FDA costs soaring and drug rejections rising
The Taxpayers Protection Alliance released a report, called Blocking Breakthroughs: Delays and Denials at the FDA, that highlights the many issues with the Food and Drug...
FDA approves Novo Nordisk’s Awiqli, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin,...
Global paediatric consumer health market to reach US$254 billion by 2032 amid growing focus on child wellness and nutrition
According to the latest market study published by Vyansa Intelligence, the global paediatric consumer health market is projected to grow at a CAGR of around 5%...
The evolution of patient expectations in medical aesthetics
Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, has announced new global consumer research highlighting how patient expectations in medical aesthetics...
Technology and Automation
Liebherr expands UK lab portfolio
Commercial refrigeration specialist Liebherr has introduced seven high performance countertop and fully integrated under bench models in their UK lab and healthcare range.
These include...
START partners with Trialing to expand access to oncology clinical trials across Europe
The START Center for Cancer Research (START), the world’s largest community-based network of clinical trial sites specialising in early-phase oncology trials, has announced a strategic...
Touch Taiwan 2026: AUO Group opens a new chapter in display innovation with AUO Display Plus Driving AI and Green Vertical Applications
As a global leader in display technologies and solutions, AUO leverages group‑wide strengths to continuously advance deployment across vertical applications. At Touch Taiwan 2026,...
Next-generation cryogenic transmission electron microscope –Glacios 3 Cryo-TEM launched
Thermo Fisher Scientific, a world leader in serving science, has introduced a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural...
AI agents to accelerate field excellence in life sciences with intelligent workflow automation
ACTO AI, a powerful new suite of 17 AI workflow agents designed to streamline and automate critical tasks across the ACTO platform, has been launched.
Built...
Pharma packaging and logistics
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility...
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, has announced a significant expansion into a new innovation hub...
Delivery routes expanded and order cut-off times for midwest and west coast customers extended
Smith Drug Company, the industry's largest wholesaler dedicated exclusively to independent retail and long-term care pharmacies, has announced a series of operational enhancements designed...
Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with...
Samsung Biologics expands US manufacturing capacity with acquisition from GSK
Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...
Natix goes to China to enhance manufacturing
To answer the global shortage of high-activity Pancrelipase/Pancreatin Enzybel Pharma 2, Natix has forged a strategic alliance with Deebio, a prominent Chinese manufacturer of...
Events and conferences
Inaugural International Brain Health Conference 2026 to focus on early intervention before dementia
International Brain Health Conference 2026 18–19 May 2026 Sheraton Grand Hotel, Edinburgh, UK
An international conference bringing together global leaders in neuroscience, clinical research, public health, and...
Cambridge’s grassroots life sciences showcase branches out to Oxford and London
Cambridge Wide Open Week (CWOW) returns 11–19 June 2026, sharing the spirit and buzz of the week-long, interactive festival with Oxford and London for...
Major growth in visitor numbers, full halls, clear future topics: Analytica 2026 sets standards
1,135 exhibitors from 40 countries
About 35,000 visitors from 115 countries
AI and automation as innovation drivers for the industry
Full halls, more visitors, highly satisfied exhibitors:...
Interphex week Tokyo 2026 conference programme announced
Featuring 320 sessions across manufacturing, quality, CMC, and digital transformation, the conference programme for Interphex week Tokyo 2026, Japan’s largest pharma and biotech gathering...
Life sciences congress descends on Lisbon
25-26 March | Lisbon Congress Centre | Lisbon | Portugal
For over a decade, LSX Europe has brought together the leaders shaping the future of...
Funding and Finance
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Eli Lilly and Company and Centessa Pharmaceuticals, a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other...
Ellison purchase swells triangle’s lab space
Oxfordshire, a key part of UK life sciences’ Golden Triangle region, had an annual take-up of lab space last year amounting to 620,200 sq...
Seda accelerates global pharma growth with £15m backing from BGF
BGF, the UK and Ireland’s most active growth capital investor, has completed a £15 million investment in Seda Pharma Development Services Ltd (Seda), an integrated...
Enzymatica and STADA sign partnership agreement for Germany and Austria
Enzymatica AB and STADA Arzneimittel AG have entered into a partnership agreement regarding the launch and distribution of Enzymatica’s ColdZyme® oral-spray technology in Germany...
Otsuka merges with Transcend in a deal worth around $1.2 billion
Otsuka and Transcend Therapeutics have announced an agreement under which Otsuka, through its wholly owned subsidiary Otsuka America, will fully acquire Transcend.
The acquisition is...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
MOST POPULAR POSTS
© 2026 Pharma Press Publishing.